Married couple battling concurrent stage IV CRC diagnoses speaks at Denver Bash
The average odds of getting colorectal cancer in your lifetime are 1 in 24.
The average odds of getting it before you turn 45 are 1 in 240.
But, as Erik Stanley shared with Blue Hope Bash Denver guests this weekend, the odds of a married couple under 45 — who grew up 1,000 miles apart and without any genetic predisposition — both being diagnosed with stage IV colon cancer within two years are about 1 in 100 million.
That’s exactly what Erik and his wife, Kacie Peters, are facing today.
“Since our diagnoses, we’ve done over 100 hours of chemotherapy, had a dozen surgeries with more to come, and spent at least 65 nights away from home in the hospital,” Kacie told Bash guests.
“And we’ve done it all so that our 5-year-old son doesn’t have to grow up without us,” Erik added.
Kacie and Erik are extraordinary. Despite dual, concurrent diagnoses with stage IV colorectal cancer, they have risen to the challenges posed by this disease and continue to be incredible parents, accomplished professionals, and now, outspoken advocates for colorectal cancer.
They spoke at the Blue Hope Bash Denver on October 1 to encourage support for the Alliance’s mission and raise funds to research new treatments and find a cure.
You can support them in the cause by donating here.
The Alliance is the nation’s leading nonprofit dedicated to ending colorectal cancer. Through programs to screen, care, and cure this disease, we will end this disease in our lifetime.
Top resources
HAI liver pump for mCRC offers second chances
Discover how Hope overcame stage IV colorectal cancer with an innovative HAI liver pump, staying active and proving that second chances are possible.
Treatment for KRAS G12C-mutated metastatic CRC approved by FDA
The U.S. Food and Drug Administration has approved sotorasib in combination with panitumumab for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer.
Watch session videos from AllyCon 2024
Watch videos of two major general sessions from AllyCon 2024, the Alliance's patient support conference, which took place in Miami Beach in December.